IL-33/ST2 pathway and classical cytokines in end-stage heart failure patients submitted to left ventricular assist device support: A paradoxic role for inflammatory mediators?

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Caselli, C ^a   D'Amico, A ^b   Ragusa, R ^a   Caruso, R ^c   Prescimone, T ^a   Cabiati, M ^a   Nonini, S ^c   Marraccini, P ^a,c   Del Ry, S ^a   Trivella, M G ^a   Parodi, O ^a,c   Giannessi, D ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CELL SURFACE RECEPTOR; CYTOKINE; IL1RL1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ARTICLE; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CYTOKINES; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 84893875685     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/498703     Document Type: Article

References (29)

1. Jiang B., Liao R., The paradoxical role of inflammation in cardiac repair and regeneration. Journal of Cardiovascular Translational Research 2010 3 4 410 416 2-s2.0-77955510430 10.1007/s12265-010-9193-7
2. Shimano M., Ouchi N., Walsh K., Cardiokines: recent progress in elucidating the cardiac secretome. Circulation 2012 126 21 e327 e332 10.1161/CIRCULATIONAHA.112.150656
3. Kleinbongard P., Schulz R., Heusch G., TNF α in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Failure Reviews 2011 16 1 49 69 2-s2.0-78650971588 10.1007/s10741-010-9180-8
4. Schultz J. E. J., Witt S. A., Glascock B. J., Nieman M. L., Reiser P. J., Nix S. L., Kimballand T. R., Doetschman T., TGF- β 1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. Journal of Clinical Investigation 2002 109 6 787 796 2-s2.0-0036009157 10.1172/JCI200214190 (Pubitemid 34263155)
5. Ambardekar A. V., Buttrick P. M., Reverse remodeling with left ventricular assist devices a review of clinical, cellular, and molecular effects. Circulation: Heart Failure 2011 4 2 224 233 2-s2.0-79955929563 10.1161/CIRCHEARTFAILURE.110.959684
6. Heymans S., Hirsch E., Anker S. D., Aukrust P., Balligand J.-L., Cohen-Tervaert J. W., Drexler H., Filippatos G., Felix S. B., Gullestad L., Hilfiker-Kleiner D., Janssens S., Latini R., Neubauer G., Paulus W. J., Pieske B., Ponikowski P., Schroen B., Schultheiss H.-P., Tschöpe C., Van Bilsen M., Zannad F., McMurray J., Shah A. M., Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure 2009 11 2 119 129 2-s2.0-64549091508 10.1093/eurjhf/hfn043
7. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T. K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D. M., Bazan J. F., Kastelein R. A., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005 23 5 479 490 2-s2.0-27744446058 10.1016/j.immuni.2005.09.015 (Pubitemid 41587888)
8. Dinarello C. A., An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity 2005 23 5 461 462 2-s2.0-27744438007 10.1016/j.immuni.2005.10.004 (Pubitemid 41587885)
9. Sanada S., Hakuno D., Higgins L. J., Schreiter E. R., McKenzie A. N. J., Lee R. T., IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. Journal of Clinical Investigation 2007 117 6 1538 1549 2-s2.0-34249882513 10.1172/JCI30634 (Pubitemid 46871338)
10. Seki K., Sanada S., Kudinova A. Y., Steinhauser M. L., Handa V., Gannon J., Lee R. T., Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circulation: Heart Failure 2009 2 6 684 691 2-s2.0-77949264462 10.1161/CIRCHEARTFAILURE.109.873240
11. Abston E. D., Barin J. G., Cihakova D., Bucek A., Coronado M. J., Brandt J. E., Bedja D., Kim J. B., Georgakopoulos D., Gabrielson K. L., Mitzner W., Fairweather D., IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function. Circulation: Heart Failure 2012 5 366 375
12. McMurray J. J., Adamopoulos S., Anker S. D., Auricchio A., Bohm M., Dickstein K., Falk V., Filippatos G., Fonseca C., Gomez-Sanchez M. A., Jaarsma T., Kober L., Lip G. Y., Maggioni A. P., Parkhomenko A., Pieske B. M., Popescu B. A., Ronnevik P. K., Rutten F. H., Schwitter J., Seferovic P., Stepinska J., Trindade P. T., Voors A. A., Zannad F., Zeiher A., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal 2012 33 14 1787 1847 10.1093/eurheartj/ehs104
13. Rose E. A., Gelijns A. C., Moskowitz A. J., Heitjan D. F., Stevenson L. W., Dembitsky W., Long J. W., Ascheim D. D., Tierney A. R., Levitan R. G., Watson J. T., Ronan N. S., Shapiro P. A., Lazar R. M., Miller L. W., Gupta L., Desvigne-Nickens P., Meier P., Howard Frazier O., Desvigne-Nickens P., Oz M. C., Poirier V. L., Long-term use of a left ventricular assist device for end-stage heart failure. The New England Journal of Medicine 2001 345 20 1435 1443 2-s2.0-0035892018 10.1056/NEJMoa012175
14. Slaughter M. S., Rogers J. G., Milano C. A., Russell S. D., Conte J. V., Feldman D., Sun B., Tatooles A. J., Delgado R. M. III, Long J. W., Wozniak T. C., Ghumman W., Farrar D. J., Frazier O. H., Advanced heart failure treated with continuous-flow left ventricular assist device. The New England Journal of Medicine 2009 361 23 2241 2251 2-s2.0-73349129701 10.1056/NEJMoa0909938
15. Simon M. A., Kormos R. L., Murali S., Nair P., Heffernan M., Gorcsan J., Winowich S., McNamara D. M., Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation 2005 112 9 I32 I36 2-s2.0-24644466420 10.1161/CIRCULATIONAHA.104.524124 (Pubitemid 41266650)
16. Birks E. J., Tansley P. D., Hardy J., George R. S., Bowles C. T., Burke M., Banner N. R., Khaghani A., Yacoub M. H., Left ventricular assist device and drug therapy for the reversal of heart failure. The New England Journal of Medicine 2006 355 18 1873 1884 2-s2.0-33750500333 10.1056/NEJMoa053063 (Pubitemid 44664645)
17. Chen Y.-S., Ko W.-J., Lin F.-Y., Huang S.-C., Chou T.-F., Chou N.-K., Hsu R.-B., Wang S.-S., Chu S.-H., Preliminary result of an algorithm to select proper ventricular assist devices for high-risk patients with extracorporeal membrane oxygenation support. Journal of Heart and Lung Transplantation 2001 20 8 850 857 2-s2.0-0034904392 10.1016/S1053-2498(01)00267-4 (Pubitemid 32743138)
18. Caselli C., D'Amico A., Caruso R., Cabiati M., Prescimone T., Cozzi L., Cannata A., Parodi O., Del Ry S., Giannessi D., Impact of normalization strategy on cardiac expression of pro-inflammatory cytokines: evaluation of reference genes in different human myocardial regions after Left Ventricular Assist Device support. Cytokine 2013 63 2 113 122
19. Bustin S. A., Benes V., Garson J. A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M. W., Shipley G. L., Vandesompele J., Wittwer C. T., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry 2009 55 4 611 622 2-s2.0-64149097786 10.1373/clinchem.2008.112797
20. Weinberg E. O., Shimpo M., De Keulenaer G. W., MacGillivray C., Tominaga S.-I., Solomon S. D., Rouleau J.-L., Lee R. T., Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 2002 106 23 2961 2966 2-s2.0-0037016036 10.1161/01.CIR.0000038705.69871.D9 (Pubitemid 35424749)
21. Demyanets S., Kaun C., Pentz R., Krychtiuk K. A., Rauscher S., Pfaffenberger S., Zuckermann A., Aliabadi A., Groger M., Maurer G., Huber K., Wojta J., Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. Journal of Molecular and Cellular Cardiology 2013 60 16 26
22. Miller A. M., Xu D., Asquith D. L., Denby L., Li Y., Sattar N., Baker A. H., McInnes I. B., Liew F. Y., IL-33 reduces the development of atherosclerosis. Journal of Experimental Medicine 2008 205 2 339 346 2-s2.0-39549100797 10.1084/jem.20071868 (Pubitemid 351281600)
23. Bartunek J., Delrue L., Van Durme F., Muller O., Casselman F., De Wiest B., Croes R., Verstreken S., Goethals M., de Raedt H., Sarma J., Joseph L., Vanderheyden M., Weinberg E. O., Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. Journal of the American College of Cardiology 2008 52 25 2166 2174 2-s2.0-57449089014 10.1016/j.jacc.2008.09.027
24. Boisot S., Beede J., Isakson S., Chiu A., Clopton P., Januzzi J., Maisel A. S., Fitzgerald R. L., Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure. Journal of Cardiac Failure 2008 14 9 732 738 2-s2.0-55149116551 10.1016/j.cardfail.2008.06.415
25. Wang T. J., Wollert K. C., Larson M. G., Coglianese E., McCabe E. L., Cheng S., Ho J. E., Fradley M. G., Ghorbani A., Xanthakis V., Kempf T., Benjamin E. J., Levy D., Vasan R. S., Januzzi J. L., Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 2012 126 13 1596 1604
26. Haraldsen G., Balogh J., Pollheimer J., Sponheim J., Küchler A. M., Interleukin-33-cytokine of dual function or novel alarmin? Trends in Immunology 2009 30 5 227 233 2-s2.0-65149097030 10.1016/j.it.2009.03.003
27. Miller A. M., Liew F. Y., The IL-33/ST2 pathway-a new therapeutic target in cardiovascular disease. Pharmacology and Therapeutics 2011 131 2 179 186 2-s2.0-79959709354 10.1016/j.pharmthera.2011.02.005
28. Butler C. R., Jugdutt B. I., The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly. Heart Failure Reviews 2012 17 4-5 615 633 2-s2.0-84855798805 10.1007/s10741-012-9300-8
29. Kakkar R., Lee R. T., The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nature Reviews Drug Discovery 2008 7 10 827 840 2-s2.0-53249113212 10.1038/nrd2660